Stryker Corporation
Stryker Corp. is a U.S.-based medical technology company organized around MedSurg and Neurotechnology and Orthopaedics. Its portfolio includes surgical equipment, endoscopy and patient-handling systems, neurovascular and cranial products, and joint replacement, trauma, and extremity implants sold through direct and distributor channels in roughly 61 countries.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueSurgical, endoscopy, patient care, vascular, and cranial products used across hospitals and specialty procedures.
Implants and enabling technologies for joint replacement, trauma, and extremity surgery.
Customers
Stryker sells primarily to doctors, hospitals, and other healthcare facilities that purchase devices for surgery, patient care, and procedural support. Its products are also used by healthcare organizations and distributors that serve operating rooms, emergency care, intensive care, and specialty surgical settings.
Buy surgical, patient-care, and procedural products for operating rooms, wards, and critical care units.
Use implants, navigation, and specialty devices for orthopedic and neuro procedures.
Purchase endoscopy, communications, and selected procedural technologies for outpatient care.
Resell Stryker products in markets where indirect channels are used to reach providers.
Strategy
Stryker’s strategy centers on expanding its medical technology portfolio, advancing robotics and digital-enabled care, and maintaining a broad product mix across surgery, neurotechnology, and orthopaedics. The company also emphasizes acquisitions and shareholder returns as part of its long-term capital allocation framework.
New devices and technologies help protect share in procedure-driven markets.
Acquired products can add scale, adjacent categories, and channel reach.
Automation and connectivity can differentiate products and improve adoption.
A wide geographic footprint supports growth but requires local market adaptation.
Geography
Stryker sells products in approximately 61 countries through subsidiaries, branches, and third-party distributors. The business is globally diversified, with exposure to the United States, Europe, and other international markets, and it also operates manufacturing and distribution across multiple jurisdictions.
Risks
Stryker faces supply-chain, regulatory, reimbursement, and geopolitical risks because it manufactures and sells regulated medical devices globally. Its business is also exposed to product development failure, competition from larger medtech peers and new entrants, and legal or quality issues tied to implants, procedures, and post-market surveillance.
- Product quality, recall, and litigation riskImpact: HighLikelihood: High
Implants and procedural devices can trigger claims, recalls, or regulatory actions.
Exposure: Orthopaedics and neurotechnology
- Supply chain and third-party service dependenceImpact: HighLikelihood: Medium
The company relies on raw materials, components, sterilization, and other external services.
Exposure: Global manufacturing and distribution
- Regulatory compliance and approval riskImpact: HighLikelihood: Medium
Medical devices must meet changing requirements across jurisdictions, including EU MDR.
Exposure - Innovation and competitive riskImpact: HighLikelihood: Medium
The company must keep pace with robotics, AI, and new device entrants.
Exposure - Reimbursement and pricing pressureImpact: MediumLikelihood: Medium
Hospitals and payors influence adoption, utilization, and pricing of devices.
Exposure: Hospital and health-system customers
- Geopolitical and tariff exposureImpact: MediumLikelihood: Medium
Cross-border sourcing and sales expose the company to tariffs and trade restrictions.
Exposure
Accounting
Judgemental itemsManagement uses discounted cash flow and other valuation inputs to test reporting units.
Impact: Can create large non-cash charges, as seen in the Spine reporting unit
Recent deals create stepped-up inventory, intangible amortization, and integration costs.
Impact: Affects operating income, taxes, and adjusted earnings comparability
Workforce reductions, facility actions, and product line exits are recorded separately.
Impact: Can distort period-to-period operating trends
Acquisition liabilities are remeasured using judgmental assumptions.
Impact: Can move other income/expense and earnings
Global operations and overseas cash balances affect tax expense and liquidity presentation.
Impact: Can create volatility in effective tax rate and cash availability
Similar listed companies
Publicly listed companies with a comparable business focus.
Globus Medical, Inc
GMED · Surgical & Medical Instruments & Apparatus
Globus Medical is a U.S.-based medical device company focused on musculoskeletal care, with products used in spine, orthopedic trauma, hip, knee, extremity and neurosurgical procedures.
Merit Medical Systems, Inc
MMSI · Surgical & Medical Instruments & Apparatus
Merit Medical Systems designs, manufactures, and markets proprietary medical devices used in interventional, diagnostic, and therapeutic procedures.
Enovis CORP
ENOV · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Enovis is a U.S.-based medical technology company focused on orthopedic and musculoskeletal care.
Medtronic plc
MDT · Electromedical & Electrotherapeutic Apparatus
Medtronic plc designs, manufactures, and sells medical technologies used to diagnose, treat, and manage chronic and acute conditions across the body.
Boston Scientific Corporation
BSX · Surgical & Medical Instruments & Apparatus
Boston Scientific Corporation develops, manufactures, and markets medical devices used across a wide range of interventional specialties.
Baxter International Inc
BAX · Surgical & Medical Instruments & Apparatus
Last updated: 24/09/2026